4-Piperidinemethanol → HCID 59604140, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[N:8]1[C:12]([C:13]2[CH:18]=[CH:17][N:16]=[CH:15][CH:14]=2)=[C:11]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:31]=[CH:30][C:27]([CH:28]=O)=[CH:26][CH:25]=3)[N:20]=2)[N:10]=[N:9]1.[OH:32][CH2:33][CH:34]1[CH2:39][CH2:38][NH:37][CH2:36][CH2:35]1>>[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[N:8]1[C:12]([C:13]2[CH:14]=[CH:15][N:16]=[CH:17][CH:18]=2)=[C:11]([C:19]2[O:23][N:22]=[C:21]([C:24]3[CH:25]=[CH:26][C:27]([CH2:28][N:37]4[CH2:38][CH2:39][CH:34]([CH2:33][OH:32])[CH2:35][CH2:36]4)=[CH:30][CH:31]=3)[N:20]=2)[N:10]=[N:9]1Participants
Procedure
The title compound was prepared following the procedure described for Example 94, but starting from 4-(5-(1-(2-fluorophenyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-3-yl)benzaldehyde, obtained as described in Example 113, Step 1, (100 mg; 0.24 mmol) and 4-hydroxymethylpiperidine (55.9 mg; 0.48 mmol) to give Example 139 as a white solid. 1H NMR: (DMSO-d6, 400 MHz) δ 8.75 (2H, dd, J=4.48, 1.64 Hz), 7.97-7.86 (3H, m), 7.76-7.69 (1H, m), 7.61 (2H, dd, J=4.5, 1.7 Hz), 7.55-7.48 (4H, m), 4.43 (1H, t, J=5.3 Hz), 3.55 (2H, s), 3.28 (2H, t, J=5.8 Hz), 2.84 (2H, d, J=10.8 Hz), 1.96 (2H, t, J=11.3 Hz), 1.66 (2H, d, J=12.6 Hz), 1.37 (1H, d, J=10.8 Hz), 1.25-1.12 (2H, m). LC/MS (Method C): 512 (M+H)+. HPLC (Method E) Rt 2.16 min (Purity: 99.2%).
Workup
- customobtained
Sources & evidence
- ORD record
- ord-25e1693f74ef4ea5ac4cfa1c0e712983
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08202856B2
Reaction notes
Loading…